Vimarsana
Biggest News Aggregation in the World

Clinical Collaborators News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Clinical Collaborators. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Clinical Collaborators Today - Breaking & Trending Today

Registry Reveals Sex Differences in HoFH Diagnosis, Treatment, and Cardiovascular Outcomes - Vimarsana News

Registry Reveals Sex Differences in HoFH Diagnosis, Treatment, and Cardiovascular Outcomes

Although the prevalence of myocardial infarction (MI) was doubled among men compared with women with homozygous familial hypercholesterolemia (HoFH), both sexes had similar ages at first MI.

Source: ajmc.com
Half of Deaths From Homozygous FH Occur Before Age 32 Years - Vimarsana News

Half of Deaths From Homozygous FH Occur Before Age 32 Years

The median age of death from homozygous familial hypercholesterolemia is just 32 years, with many patients having had poor lipid control, shows registry data described by one expert as "terrifying."

High LDL, Poor Treatment, Early Death: HoFH Registry Paints Grim Picture - Vimarsana News

High LDL, Poor Treatment, Early Death: HoFH Registry Paints Grim Picture

Among those who died with this rare genetic lipid disorder, half did so before they reached their third decade.

Source: tctmd.com
Vascudyne Announces Presentation of First Clinical Results of TRUE AVC™ in Hemodialysis Access at the VASA Conference - Vimarsana News

Vascudyne Announces Presentation of First Clinical Results of TRUE AVC™ in Hemodialysis Access at the VASA Conference

Press release content from News Direct Corporation. The AP news staff was not involved in its creation.

Source: apnews.com
HBKU part of global study on rare inherited cholesterol disorder - Vimarsana News

HBKU part of global study on rare inherited cholesterol disorder

A faculty member at Hamad Bin Khalifa University’s College of Health and Life Sciences (CHLS) recently took part in a global clinical collaboration to study a